Our previous studies have revealed potent synthetic activities (e.g., PPi:-,ATP:-, and carbamyl-P:glucose phosphotransferase) catalyzed by D-glucose-6-P phosphohydrolase (EC 3.1.3.9). These activities intrinsically exceed both this enzyme's capacity for glucose-6-P hydrolysis and the combined phosphorylative action of hepatic hexokinase plus glucokinase. 1. A major emphasis will now be placed on assessing metabolic functions which these synthetic activities may play in living cells, especially as they may complement hexokinase and glucokinase in glucose phosphorylation. The possibility of kinase-specific metabolic channeling will be considered. 2. Roles for both phosphotransferase and phosphohydrolase activities of hepatic glucose-6-phosphatase in control of ambient blood glucose levels normally and under various perturbed conditions will be explored. Perfused rat and avian livers and isolated hepatic parenchymal cells will be employed, and rates of glucose phosphorylation directly attributable to the subject phosphotransferase will be measured by 3H-release from 2-3H-D-glucose. Alterations in blood glucose levels through differential readjustment (""""""""retuning"""""""") of rates of enzymic glucose phosphorylation and glucose-6-P hydrolysis will be considered in various species under normal conditions, in diabetes, fasting, ageing, congenital hyper- and hypoglycemia, and hormonally, nutritionally, and pharmacological alters states. 3. The multifunctional enzyme newly demonstrated in brain, pancreas, adrenals, tests, and lung will be further studied with respect to comparative catalytic characteristics; hormonally, nutritionally and chemotherapeutically induced responses; and probable metabolic roles. Also included will be: 4) extensions of distribution of studies, 5) studies of activity-discriminant control through membrane-enzyme interactions; the effects of the hormones somatostatin, glucagon, and insulin; and Cu2 ion and other divalent cations, 6) a search for additional activities previously overlooked, including protein kinase activity, and 7) investigations of possible involvement of the enzyme in mediated cellular and intracellular (nuclear) glucose transport.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
5R01AM007141-23
Application #
3150730
Study Section
Biochemistry Study Section (BIO)
Project Start
1976-09-01
Project End
1987-08-31
Budget Start
1985-09-01
Budget End
1987-08-31
Support Year
23
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of North Dakota
Department
Type
Schools of Medicine
DUNS #
102280781
City
Grand Forks
State
ND
Country
United States
Zip Code
58202